Despite Our Losses, People with ME/CFS Want More
We've been cheated by ME/CFS and we all know it. That's a no-brainer, if you'll pardon the cognitive pun. And loss didn't just result from the bad things that befell us. It also encompasses the good things that just ... never came. The absence of bounty. Of wholeness. Of peace.
Discuss the article on the Forums.

FDA Proposal to Remove Midodrine from Market

Discussion in 'General ME/CFS News' started by Andrew, Aug 26, 2010.

  1. Andrew

    Andrew Senior Member

    Los Angeles, USA
    From the IACFSME

    Here are some references about the drug, taken from Broken Marionette

    Duschek S, Hadjamu M, Schandry R. Enhancement of cerebral blood
    flow and cognitive performance following pharmacological blood pressure
    elevation in chronic hypotension. Psychophysiology. 2007 Jan;44

    AACFS conference January 2001. Report by Dr. Rosamund Vallings.

    Naschitz J, Dreyfuss D, Yeshurun D, et al. Midodrine treatment for
    chronic fatigue syndrome. Postgrad Med J. 2004 Apr;80(942):230–2.

    Naschitz JE, Rosner I, Rozenbaum M, et al. Successful treatment of
    chronic fatigue syndrome with midodrine: a pilot study. Clin Exp Rheumatol.
    2003 May–Jun;21(3):416–7.

    Goldstein Jay. Tuning the Brain: Principles and Practice of Neurosomatic
    Medicine. Haworth Press 2004. p. 93.
  2. ahimsa

    ahimsa Rarely on PR now

    This is going to affect a lot of patients in the USA. I think I read in one article that there were about 100,000 prescriptions for midodrine last year?

    Here's an interesting analysis of the conflict between the business issues and the FDA regulation rules:

    "Pill pickle: Hypotension drug quandary spotlights tough FDA's dilemma"

    For those who are taking this drug and who want to take action the Dysautonomia Youth Network of America web site has an "urgent call to action" web page all about contacting the FDA:

See more popular forum discussions.

Share This Page